相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Short-Term Outcomes of Aflibercept for Neovascular Age-Related Macular Degeneration in Eyes Previously Treated With Other Vascular Endothelial Growth Factor Inhibitors
Vincent Y. Ho et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration
Davin Johnson et al.
CURRENT OPINION IN OPHTHALMOLOGY (2013)
Acute Intraocular Inflammation Caused by Endotoxin after Intravitreal Injection of Counterfeit Bevacizumab in Shanghai, China
Fenghua Wang et al.
OPHTHALMOLOGY (2013)
Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
Brandon G. Busbee et al.
OPHTHALMOLOGY (2013)
Acute Anterior Uveitis Following Intravitreal Injection of Bevacizumab
Arash Mozayan et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2013)
Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
Nicholas Papadopoulos et al.
ANGIOGENESIS (2012)
Rate of serious adverse effects in a series of bevacizumab and ranibizumab injections
Sanjay Sharma et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2012)
Pharmacokinetic Properties of Intravitreal I-124-Aflibercept in a Rabbit Model Using PET/CT
John B. Christoforidis et al.
CURRENT EYE RESEARCH (2012)
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Usha Chakravarthy et al.
OPHTHALMOLOGY (2012)
Uveitis Following Intravitreal Bevacizumab: A Non-Infectious Cluster
Christine N. Kay et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2011)
Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
Frank G. Holz et al.
OPHTHALMOLOGY (2011)
Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
Chirag P. Shah et al.
OPHTHALMOLOGY (2011)
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
Michael Tolentino
SURVEY OF OPHTHALMOLOGY (2011)
PET/CT Imaging of I-124-Radiolabeled Bevacizumab and Ranibizumab after Intravitreal Injection in a Rabbit Model
John B. Christoforidis et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Incidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: a retrospective cohort study
Davin Johnson et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2010)
Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy
K. Ghasemi Falavarjani et al.
EYE (2010)
A review of clinical trials of anti-VEGF agents for diabetic retinopathy
Benjamin P. Nicholson et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage
Hossein Nazari et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Severe Intraocular Inflammation after Intravitreal Injection of Bevacizumab
Tatsuhiko Sato et al.
OPHTHALMOLOGY (2010)
CHARACTERIZATION OF STERILE INTRAOCULAR INFLAMMATORY RESPONSES AFTER INTRAVITREAL BEVACIZUMAB INJECTION
Deborah Y. Chong et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
STERILE ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB OBTAINED FROM A SINGLE BATCH
Kenji Yamashiro et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results
Peng Zou et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2010)
Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)
M. Georgopoulos et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
SAFETY OF REPEAT INTRAVITREAL INJECTIONS OF BEVACIZUMAB VERSUS RANIBIZUMAB Our Experience After 2,000 Injections
Ioannis D. Ladas et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
EVALUATION OF SAFETY FOR BILATERAL SAME-DAY INTRAVITREAL INJECTIONS OF ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Luiz H. Lima et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Complications in patients after intravitreal injection of bevacizumab
Chiharu Shima et al.
ACTA OPHTHALMOLOGICA (2008)
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): Year 2 results
Andrew N. Antoszyk et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1
Carl D. Regillo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
L. J. Singerman et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Intraocular inflammation following intravitreal injection of bevacizumab
Sophie J. Bakri et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Acute Intraocular Inflammation after Intravitreous Injections of Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Sanjeewa S. Wickremasinghe et al.
OPHTHALMOLOGY (2008)
Vitreous levels of bevackumab and vascular endothelial growth factor-A in patients with choroidal neovascularization
Qi Zhu et al.
OPHTHALMOLOGY (2008)
Twelve-month safety of intravitreal injections of bevacizumab (Avastin (R)): results of the Pan-American Collaborative Retina Study Group (PACORES)
Lihteh Wu et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Pharmacokinetics of intravitreal bevackumab (avastin)
Sophie J. Bakri et al.
OPHTHALMOLOGY (2007)
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration - Year 1 results of the FOCUS study
Jeffrey S. Heier et al.
ARCHIVES OF OPHTHALMOLOGY (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration
Napoleone Ferrara et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema
Dal W. Chun et al.
OPHTHALMOLOGY (2006)
Pegaptanib sodium for neovascular age-related macular degeneration - Two-year safety results of the two prospective, multicenter, controlled clinical trials
Donald J. D'Amico
OPHTHALMOLOGY (2006)
Tolerability and efficacy of multiple escalating doses of ranibizumab (lucentis) for neovascular age-related macular degeneration
PJ Rosenfeld et al.
OPHTHALMOLOGY (2006)
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
EWM Ng et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys
DW Drolet et al.
PHARMACEUTICAL RESEARCH (2000)
分享论文
